| 12:40-13:10 | 企业专题会 |
HPV 分型定量结合甲基化检测新技术在宫颈与子宫内膜双癌筛查中的应用价值 |
|
||||
| 13:10-13:30 | 企业专题会 |
妇科肿瘤分子分型与个体化诊疗:多学科对话推动临床决策优化 |
|
||||
| 13:30-13:35 | 讨论 |
讨论主题:肿瘤分子分型在临床诊疗中的实践应用 |
|
||||
| 13:35-13:40 | 讨论 |
讨论主题:分子检测与免疫组化结果不一致情况讨论 |
|
||||
| 14:05-14:40 | 专题发言 |
如何恰当表述妇科病理诊断 |
|
||||
| 14:40-15:15 | 专题发言 |
子宫内膜息肉的病理诊断与恶变研究进展 |
|
||||
| 15:15-15:50 | 专题发言 |
卵巢癌中FRa(FOLR1)免疫组化检测及临床应用专家共识 |
|
||||
| 15:50-16:00 | 发言交流 |
肿瘤浸润淋巴细胞及三级淋巴结构的空间分布模式对子宫内膜癌预后的价值 |
|
||||
| 16:00-16:10 | 发言交流 |
DNA Methylation Drives the Immunosuppressive Tumour Microenvironment in Metastatic Endometrial Clear Cell Carcinoma |
|
||||
| 16:10-16:20 | 发言交流 |
子宫内膜癌p53亚克隆表达的特征及其分子表型特点 |
|
||||
| 16:20-16:30 | 发言交流 |
Clinicopathological Characteristics and Prognostic Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas: A Retrospective Cohort Study |
|
||||
| 16:30-16:40 | 发言交流 |
妇科肿瘤中HER2的肿瘤内异质性:单中心357例病例分析 |
|
||||
| 16:40-16:50 | 发言交流 |
A Single-Center Experience with HER2 Testing and Low-Level HER2 Expression in Cervical Squamous Cell Carcinoma: A Mono-Institutional Study of 486 Cases in China. |
|
||||
| 16:55-17:05 | 发言交流 |
解析UTROSCT异质性:结合系统性的临床病理评估与分子图谱分析以优化风险分层 |
|
||||
| 17:05-17:15 | 发言交流 |
Clinicopathological and Molecular Features of Gynecologic Perivascular Epithelioid Cell Tumors: A Single-Center Study |
|
||||
| 17:15-17:25 | 发言交流 |
HMGA2-RAD51B融合相关子宫平滑肌肿瘤呈现腹膜播散及肺转移的罕见病例临床病理学分析 |
|
||||
| 17:25-17:35 | 发言交流 |
87例类似平滑肌瘤的子宫炎性肌纤维母细胞肿瘤的临床病理及分子遗传学特征分析 |
|
||||
| 17:35-17:45 | 发言交流 |
Decoding the Methylation-Expression Axis: Unveiling Molecular-Pathological Links in Endocervical Gastric-Type Adenocarcinoma |
|
||||
| 17:45-17:55 | 发言交流 |
The clinicopathological characteristic of endocervical gastric-type adenocarcinoma and the immunoexpression of claudin18.2 and the mutation surrogate marker DCP4/SMAD4, P53, and CDK4 on the cell cycle pathway |
|
||||
| 17:55-18:00 | 总结 |
总结 |
|
||||